Versatile inorganic-organic hybrid WO x -ethylenediamine nanowires: Synthesis,mechanism and application in heavy metal ion adsorption and catalysis

Inorganic-organic hybrid WOx-ethylenediamine （WO/-EDA） nanowires have been produced by a simple, low-cost and high-yield solvothermal method. These WO/-EDA hybrid nanowires have unique lamellar mesostructures with an alternate stacking of an interconnected [WO6] octahedral layer and a monolayer of ethylenediamine molecules. This hybrid structure integrated the functionality of ethylenediamine with the stability of the WOx frameworks. In situ synchrotron- radiation X-ray diffraction is used to elucidate a possible formation mechanism of the hybrid WOx-EDA. The nanowire morphology, lamellar structure and abundant functional amino groups endow them with versatile abilities. For example, in heavy metal ion adsorption the WOx-EDA nanowires display exceptional adsorption capabilities of 925 mg·g^-1 for Pb^2＋ and 610 mg·g^-1 for UO2^2＋. The nanowires also show outstanding stability and activity as a heterogeneous base catalyst in the Knoevenagel condensation reaction at room temperature. The catalyst can be recycled and reused for 20 cycles with nearly 100% yields. This study provides a new strategy to design inorganic-organic hybrid materials, and offers a multifunctional material that is a highly efficient adsorbent and sustainable catalyst.     

Intracellularly Degradable Hydrogen‐Bonded Polymer Capsules

The assembly of low‐fouling polymer capsules with redox‐responsive behavior and intracellular degradability is reported. Thiol‐containing poly(2‐ethyl‐2‐oxazoline) (PEtOxMA_SH) brushes are synthesized by atom transfer radical polymerization (ATRP) of oligo(2‐ethyl‐2‐oxazoline)methacrylate and glycidyl methacrylate (GMA) and subsequent ring‐opening reaction of the GMA. Sequential deposition of PEtOxMA_SH/poly(methacrylic acid) (PMA) multilayers onto silica (SiO₂) particle templates and crosslinking through disulfide formation yield stable capsules after the removal of the SiO₂ templates by buffered hydrofluoric acid (HF). The redox‐responsive nature of the disulfide crosslinking groups enables the degradation of these capsules under simulated intracellular conditions at pH 5.9 and 5 mm glutathione (GSH). Furthermore, capsule degradation is observed after incubation with dendritic (JAWS II) cells. Even at high capsule‐to‐cell ratios, PEtOxMA_SH capsules show only negligible cytotoxicity. Quartz crystal microgravimetry (QCM) studies, using 100% human serum, reveal that films prepared from PEtOxMA_SH exhibit low‐fouling properties. The degradation and low‐fouling properties are promising for application of PEtOxMA_SH films/capsules for the delivery and triggered release of therapeutics.     

Relevance of Plasma Homocysteine and Methylenetetrahydrofolate Reductase 677TT Genotype in Sickle Cell Disease: A Systematic Review and Meta-Analysis

We evaluated the relevance of plasma homocysteine (HC) and the TT genotype of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism (rs1801133) in sickle cell disease (SCD) and associated vaso-occlusive crisis (VOC) and ischemic stroke (IS). We identified in Embase and Medline 22 studies on plasma HC and 22 on MTHFR genotypes. Due to age-related HC differences, adult and paediatric SCD were separated: 879 adult SCD and 834 controls (CTR) yielded a neutral effect size; 427 paediatric SCD and 625 CTR favoured SCD (p = 0.001) with wide heterogeneity (I² = 95.5%) and were sub-grouped by country: six studies (Dutch Antilles n = 1, USA n = 5) yielded a neutral effect size, four (India n = 1, Arab countries n = 3) favoured SCD (p < 0.0001). Moreover, 249 SCD in VOC and 419 out of VOC yielded a neutral effect size. The pooled prevalence of the MTHFR TT genotype in 267 SCD equalled that of 1199 CTR (4.26% vs. 2.86%, p = 0.45), and in 84 SCD with IS equalled that of 86 without IS (5.9% vs. 3.7%, p = 0.47); removal of one paediatric study yielded a significant effect size (p = 0.006). Plasma HC in paediatric SCD from Middle East and India was higher, possibly due to vitamin deficiencies. Despite its low prevalence in SCD, the MTHFR TT genotype relates to adult IS.     

How Can We Improve Vaccination Response in Old People? Part I: Targeting Immunosenescence of Innate Immunity Cells

Vaccination, being able to prevent millions of cases of infectious diseases around the world every year, is the most effective medical intervention ever introduced. However, immunosenescence makes vaccines less effective in providing protection to older people. Although most studies explain that this is mainly due to the immunosenescence of T and B cells, the immunosenescence of innate immunity can also be a significant contributing factor. Alterations in function, number, subset, and distribution of blood neutrophils, monocytes, and natural killer and dendritic cells are detected in aging, thus potentially reducing the efficacy of vaccines in older individuals. In this paper, we focus on the immunosenescence of the innate blood immune cells. We discuss possible strategies to counteract the immunosenescence of innate immunity in order to improve the response to vaccination. In particular, we focus on advances in understanding the role and the development of new adjuvants, such as TLR agonists, considered a promising strategy to increase vaccination efficiency in older individuals.